Gentherm's third quarter delivered a clean top line and a deeply disappointing bottom line. Adjusted earnings of $0.33 per share fell 50.0% short of the $0.66 consensus and were down 54.8% from $0.73 a year ago. Revenue of $405.1 million edged past the $404.4 million estimate by 0.2% and grew 4.7% year over year. On a GAAP basis, the company swung to a loss of $0.08 per share from a profit of $0.49. The headline guidance raise is real but needs context: the jump in full-year targets comes almost entirely from folding in Modine Performance Technologies, which closed October 1, rather than from improvement in the legacy business. That is the central tension. The company now has more revenue and more strategic options, while the core business is converting less of each sales dollar into profit.

The quality of the miss deserves scrutiny. Gross margin slipped to 23.3% from 24.6%, which management attributed to foreign exchange, higher net material costs and inflation, partly offset by operating leverage. Adjusted EBITDA fell to $45.0 million from $49.0 million, and the 11.1% margin continued a sequential slide from 12.5% in Q1 and 11.7% in Q2. Adjusted operating expenses rose to $65.4 million from $61.6 million, reflecting the IME acquisition, systems depreciation and personnel. Below the operating line, taxes did significant damage. Income tax expense of $13.4 million exceeded pre-tax income of $10.8 million, and a higher tax rate was a major factor in the collapse in adjusted EPS. Cash generation also softened. Q3 operating cash flow was $33.7 million versus $56.1 million, and nine-month adjusted free cash flow was $59.5 million versus $72.3 million.

The revenue story is also decelerating. Growth slowed to 4.7% from 11% in Q2 and 11.3% in Q1. Strength remained concentrated in Automotive Climate and Comfort Solutions, up 8.8% and roughly 12 points ahead of light vehicle production. Lumbar and massage rose 27.1%, and China domestic OEM sales exceeded global OEM sales for the first time. The drag came from Valve Systems, down 11.8%, and Other Automotive, down 28.0%. Medical grew 14.6% on a small base.

The most telling call disclosure involved the legacy outlook. Revenue is tracking toward the high end of the range, yet legacy EBITDA is being held near the midpoint. Management pointed to material and especially freight inflation that accelerated after July, with longer customer recovery lags and no contractual escalators, and expects that lag to persist into 2027. In other words, revenue upside is no longer reaching earnings.

The outlook for Modine carries the same issue. Its implied Q4 contribution of roughly $275 million in revenue and $28 million in adjusted EBITDA works out to about a 10% margin, below the roughly 11% framed at announcement. The new full-year guide calls for $1.825 billion to $1.925 billion in revenue, $210 million to $230 million in adjusted EBITDA and $100 million to $120 million in adjusted free cash flow.

The call did preserve a credible long-term growth narrative:

• **New business awards:** Q3 awards totaled $555 million, bringing the year-to-date total above $1.6 billion. That keeps Gentherm on track for at least $2 billion for a fourth straight year.
• **Revenue synergies:** A roughly $25 million India award through the Modine footprint gave the deal its first synergy proof point. Management acknowledged, however, that synergies are back-end loaded toward 2029-2030.
• **2027 legacy target:** Management reaffirmed $1.7 billion in legacy revenue for 2027.
• **Pro forma earnings power:** Trailing pro forma adjusted EBITDA was lifted $20 million to $346 million on $2.7 billion of revenue.
• **Home and office:** Bears have ammunition here. Near-term visibility was framed at about $30 million annualized by 2028, versus the $50 million to $100 million framing used earlier in the year.

Capital returns are the most immediate support. Gentherm repurchased $60 million of stock after closing and expects at least that much again in Q4, with $340 million of authorization remaining. That came alongside a $63.5 million special dividend. The CFO said plainly that the share price does not reflect the company's value. With pro forma leverage of about 0.8x, below the roughly 1x expected earlier, the balance sheet can support that stance.

The market had already turned against the stock before the report. Shares spiked to a 52-week high of $48.35 the day after the July report, then gave back the move and more. They entered this report at $28.44, down 23.4% from the post-July open, 41.2% off that high and 17.0% below the 200-day moving average. The stock sat just 1.9% above its inter-earnings low of $27.92, set the day before the release. Investor sentiment moved from roughly neutral at -0.04 to a more clearly negative -0.19. Price and AVWAP trend readings remain negative, consistent with that pressure.

The bottom line is that Gentherm's quarter split into two stories. The strategic transformation is on schedule, with bookings, buybacks and acquired scale supporting it. The operating trend points the other way, with decelerating legacy growth, a fourth straight quarter of margin pressure and an inflation lag that also extends to Modine. The guidance raise is acquisition arithmetic, not organic upside. Until margins stabilize, the depressed share price and aggressive buybacks reflect an unresolved debate rather than a settled bargain.